Neurology® Podcast

Follow Neurology® Podcast
Share on
Copy link to clipboard

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflamm…

American Academy of Neurology


    • Jan 20, 2022 LATEST EPISODE
    • weekdays NEW EPISODES
    • 27m AVG DURATION
    • 854 EPISODES

    Listeners of Neurology® Podcast that love the show mention: neurology podcast, neurologists, trainees, inflammation, residency, clinicians, always relevant, editor, date, clearly, commute, quality, resource, practical, easy, conversations, learning, excellent, informative, content.



    Search for episodes from Neurology® Podcast with a specific topic:

    Latest episodes from Neurology® Podcast

    Outcomes After Large Vessel Stroke Treated with Tenecteplase Before Thrombectomy

    Play Episode Listen Later Jan 20, 2022 17:55

    Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy, safety, and outcomes of treating large vessel occlusion stroke with tenecteplase before thrombectomy.

    A Nationwide Cohort Study of Epilepsy-Related Death in Young People

    Play Episode Listen Later Jan 17, 2022 15:49

    Dr. Halley Alexander discusses the utility of a new systematic classification of epilepsy-related mortality used in a nationwide cohort study of children and young adults in Denmark with Dr. Marius Kløvgaard.

    The Amyloid Hypothesis for Alzheimer Disease and Aducanumab

    Play Episode Listen Later Jan 13, 2022 17:33

    Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.

    Association Between Location of Epilepsy Surgery and Outcomes

    Play Episode Listen Later Jan 10, 2022 20:35

    Dr. Halley Alexander talks with Dr. Ezequiel Gleichgerrcht about the association between the anatomical location of surgical lesions and postoperative seizure outcomes in patients with temporal lobe epilepsy.

    Antiseizure Medication Withdrawal in Seizure-Free Patients

    Play Episode Listen Later Jan 5, 2022 13:59

    Dr. Halley Alexander discusses the AAN Guideline Subcommittee's practice advisory update on antiseizure medication withdrawal in seizure-free patients with Dr. Alison Pack.

    White Matter MRI Sequelae of Repetitive Head Impacts

    Play Episode Listen Later Jan 3, 2022 16:00

    Dr. Jeff Ratliff talks with Dr. Michael Alosco about the association between antemortem FLAIR white matter hyperintensities and neuropathology in brain donors exposed to repetitive head impacts.

    Concussion and Traumatic Encephalopathy Syndrome (January 2022 Neurology Recall)

    Play Episode Listen Later Jan 1, 2022 34:31

    The January 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and effects of traumatic encephalopathy syndrome (TES) and concussions. This episode features Dr. Alex Menze in conversation with Dr. Robert Stern, Dr. Nathan Churchill, and Prof. Antonio Belli, offering listeners a comprehensive understanding of the diagnosis and management of head trauma.

    70th Anniversary Interviews, Part II

    Play Episode Listen Later Dec 27, 2021 25:34

    Celebrate the 70th Anniversary of Neurology® with Part II of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.

    70th Anniversary Interviews, Part I

    Play Episode Listen Later Dec 21, 2021 26:42

    Celebrate the 70th Anniversary of Neurology® with Part I of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.

    Effectiveness of Initial Treatment for Infantile Spasms; CNS Hereditary Amyloidosis

    Play Episode Listen Later Dec 13, 2021 25:50

    In the first part of the podcast, Dr. Halley Alexander discusses the effectiveness of the three first line treatments for infantile spasms with Dr. Zachary Grinspan (00:51). In the second segment, Dr. Gordon Smith talks with Dr. Ricardo Taipa about the clinical manifestations, imaging results, and neuropathological findings associated with CNS involvement in hereditary transthyretin amyloidosis (14:53).

    COVID Vaccines and Neurology Immunotherapy; Health Disparities in Stroke Interventions

    Play Episode Listen Later Dec 6, 2021 31:23

    In the first part of the podcast, Dr. Justin Abbatemarco talks with Dr. Avi Nath, Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, about COVID-19 vaccines and neurology immunotherapy (00:56). In the second segment, Dr. Andy Southerland discusses disparities in the utilization of stroke interventions with Dr. Adam de Havenon (18:18).

    Common Issues in Stroke Management (December 2021 Neurology Recall)

    Play Episode Listen Later Dec 1, 2021 52:57

    The December 2021 replay of past episodes showcases a selection of interviews regarding the diagnosis and management of stroke. This episode features Dr. Andy Southerland and Will Rondeau in conversation with Drs. Seemant Chaturvedi, Lee Schwamm, Jyri Virta, and Sidsel Hastrup, offering listeners a review across the field of vascular neurology.

    Small Fiber Neuropathy; Representation of Women in Stroke Clinical Trials

    Play Episode Listen Later Nov 29, 2021 26:25

    In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Christopher Klein about small fiber neuropathy incidence, prevalence, longitudinal impairments, and disabilities (00:45). In the second segment, Dr. Amy Guzik discusses the representation of women in stroke clinical trials relative to the burden of disease in the population with Dr. Cheryl Carcel (16:12).

    International Headache Congress 2021; Speech Subtypes in Parkinson Disease

    Play Episode Listen Later Nov 22, 2021 20:13

    In the first part of the podcast, Dr. Tesha Monteith discusses the International Headache Society and European Headache Federation 2021 joint International Headache Congress with Dr. Patricia Pozo-Rosich (00:45). In the second segment, Dr. Jeff Ratliff talks with Dr. Jan Rusz about identifying speech subtypes in patients with Parkinson disease in response to long-term dopaminergic therapy (8:18).

    Dopamine Therapy in Early PD; Neurologic Disease Definitions with Immune Checkpoint Inhibitors

    Play Episode Listen Later Nov 15, 2021 26:56

    In the first part of the podcast, Dr. Jason Crowell discusses the AAN Guideline Subcommittee's practice guideline summary on dopaminergic therapy for motor symptoms in early Parkinson disease with Dr. Anthony Lang (00:45). In the second segment, Dr. Kathryn Nevel talks with Dr. Amanda Guidon about the development of consensus disease definitions for neurologic immune-related adverse events associated with immune checkpoint inhibitors (17:04). 

    Chronic Meningitis; MS Therapies and COVID-19

    Play Episode Listen Later Nov 8, 2021 41:13

    In the first part of the podcast, Dr. Stacey Clardy discusses the causes, features, evaluation, and treatment of chronic meningeal inflammation or infection with Dr. Allen Aksamit. In the second segment, Dr. Eoin Flanagan talks with Dr. Tomas Kalincik about the associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis (26:48).

    Aducanumab: What About the Patient?; Risk of Aneurysm Rupture After Stroke Thrombolysis

    Play Episode Listen Later Nov 1, 2021 25:48

    In the first part of the podcast, Dr. Gregg Day discusses the importance of patient participation in the decision-making process when considering the use of aducanumab for the treatment of Alzheimer disease with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center. In the second segment, Dr. Andy Southerland talks with Dr. Jyri Virta about the risk of aneurysm rupture after thrombolysis in patients with acute ischemic stroke and unruptured intracranial aneurysms.

    Lewy Body Dementia (November 2021 Neurology Recall)

    Play Episode Listen Later Nov 1, 2021 55:36

    Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine

    Play Episode Listen Later Oct 25, 2021 20:40

    In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.

    Neurologic Safety of COVID-19 Vaccines; Movement Disorders in Anti-IgLON5 Disease

    Play Episode Listen Later Oct 18, 2021 30:10

    In the first part of the podcast, Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from past vaccination programs. In the second segment, Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.

    CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome

    Play Episode Listen Later Oct 11, 2021 22:12

    In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.

    Peter Frampton on His Diagnosis of Myositis; Ethical Perspectives on Costly Drugs and Healthcare

    Play Episode Listen Later Oct 4, 2021 36:10

    In the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN's patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.

    Thunderclap Headache (October 2021 Neurology Recall)

    Play Episode Listen Later Oct 1, 2021 35:58

    The October 2021 replay of past episodes showcases a selection of interviews focused on thunderclap headache. This episode features Dr. Tesha Monteith in conversation with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, as well as with headache experts Drs. Jonathan Smith, Dileep Yavagal, and Alexandra Cocores.

    Ethical Considerations in Dementia Diagnosis; Diagnosis of Mild Cognitive Impairment

    Play Episode Listen Later Sep 27, 2021 27:05

    In the first part of the podcast, Dr. Jeff Ratliff talks with Dr. Winston Chiong about the updated AAN Position Statement on Ethical Considerations in Dementia Diagnosis and Care. In the second segment, Dr. Gregg Day talks with Dr. Emily Edmonds about differing cognitive, biomarker, and neuropathologic trajectories in subtypes of mild cognitive impairment.

    Effects of Concussions on Midline Brain Structures

    Play Episode Listen Later Sep 20, 2021 12:16

    Dr. Alex Menze discusses the acute and chronic effects of a history of concussions with Dr. Nathan Churchill.

    Comparing MRI Lesions in CNS Demyelinating Disorders; Brain Processing in Patients with Migraine

    Play Episode Listen Later Sep 13, 2021 22:47

    In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Eoin Flanagan about how MRI T-2 lesion evolution differs across central nervous system demyelinating disorders. In the second segment, Dr. Teshamae Monteith talks with Dr. Gabriela Carvalho about behavioral and neuronal responses to a virtual roller coaster ride in patients with migraine.

    Neuroprosthesis for Anarthria; Clinical Progression of LBD

    Play Episode Listen Later Sep 6, 2021 23:50

    In the first part of the podcast, Dr. Andy Southerland talks with Dr. Edward Chang about the use of a neuroprosthesis for decoding speech in a paralyzed person with anarthria. In the second segment, Dr. Jeff Ratliff discusses the trajectory and magnitude of the progression of clinical features in Lewy body dementia with Dr. Elie Matar.

    journal clinical progression neurology lewy edward chang jeff ratliff andy southerland
    Management of Myasthenia Gravis (September 2021 Neurology Recall)

    Play Episode Listen Later Sep 1, 2021 53:01

    The September 2021 replay of past episodes showcases a selection of interviews focused on the management of myasthenia gravis. The selected interviews feature Dr. Ted Burns and Dr. Stacey Clardy in conversation with Drs. Gil Wolfe, Joseph Shrager, and Pushpa Narayanaswami before closing with before closing with notes from Dr. Ted Burns on MuSK myasthenia gravis.

    Using RT-QuIC to Diagnose DLB; Central Hypersomnia in Multiple Sclerosis

    Play Episode Listen Later Aug 30, 2021 15:47

    In the first segment, Dr. Matthew Barrett talks with Dr. Simone Baiardi about using real-time quaking-induced conversion (RT-QuIC) to identify patients with Lewy body disease. In the second part of the podcast, Dr. Jeff Ratliff discusses the association of central hypersomnia and fatigue in multiple sclerosis with Dr. Anne-Laure Dubessy.

    Out-of-Pocket Costs for MS Drugs; Part 4 of the Thunderclap Headache Series

    Play Episode Listen Later Aug 23, 2021 30:00

    In the first segment, Dr. Stacey Clardy talks with Dr. Daniel Hartung about whether closing the Part D coverage gap between 2010-2019 lowered patients' out-of-pocket costs for multiple sclerosis drugs. In the second part of the podcast, Dr. Teshamae Monteith discusses sex, exercise, and other benign causes of thunderclap headache with Dr. Jonathan Smith in the final part of our four-part series on thunderclap headache.

    Patient Perceptions of FDA Approval; Part 3 of the Thunderclap Headache Series

    Play Episode Listen Later Aug 16, 2021 23:00

    In the first segment, Dr. Jason Crowell talks with Dr. Paul Ford about patient perceptions of the FDA approval process for disease modifying therapies in people living with multiple sclerosis. In the second part of the podcast, Dr. Teshamae Monteith discusses the management of cerebral aneurysm with Dr. Dileep Yavagal in the third part of our four-part series on thunderclap headache.

    Coma Induction in Status Epilepticus; Part 2 of the Thunderclap Headache Series

    Play Episode Listen Later Aug 9, 2021 22:34

    In the first segment, Dr. Halley Alexander talks with Dr. Pia De Stefano about the safety and efficacy of artificial coma induction in the treatment of status epilepticus. In the second part of the podcast, Dr. Teshamae Monteith discusses a case presentation of RCVS and clinical management with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, in the second part of our four-part series on thunderclap headache. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week's Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.

    Psychogenic Nonepileptic Seizures in Children and Adolescents; Part 1 of the Thunderclap Headache Series

    Play Episode Listen Later Aug 2, 2021 22:37

    In the first segment, Dr. Jon Stone talks with Dr. Anne Sofie Hansen about the spectrum and risk of psychiatric disorders in childhood-onset psychogenic nonepileptic seizures. In the second part of the podcast, Dr. Teshamae Monteith discusses ten causes of thunderclap headache and presentation with Dr. Alexandra Cocores in the first part of our four-part series on thunderclap headache. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week's Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.

    Perspectives on Aducanumab Approval (Neurology Recall August 2021)

    Play Episode Listen Later Aug 1, 2021 88:37

    This month's replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.

    Impact of Thymectomy on Myasthenia Gravis Remission

    Play Episode Listen Later Jul 26, 2021 16:58

    Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.

    Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation

    Play Episode Listen Later Jul 19, 2021 25:58

    In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.

    Illness in Overseas U.S. Embassies Employees; Afferent Baroreflex Failure

    Play Episode Listen Later Jul 12, 2021 29:35

    In the first segment, Dr. Alex Menze talks with Dr. Clifford Saper about Havana Syndrome and recent attacks on American diplomats. In the second part of the podcast, Dr. Jeff Ratliff discusses the natural history of afferent baroreflex failure with Dr. Guillaume Lamotte.

    Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's

    Play Episode Listen Later Jul 5, 2021 31:00

    In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer's disease diagnosis and experience participating in a clinical trial for aducanumab.

    Management of Neurologic Conditions in Pregnancy (Neurology Recall July 2021)

    Play Episode Listen Later Jul 1, 2021 79:06

    This month's replay of past episodes showcases a selection of interviews on the impact of pregnancy on various neurologic disorders, featuring Drs. Page Pennell, Paula Emanuela Voinescu, Mary Angela O'Neal, Emma Ciafaloni, Raed Alroughani, Rae Bacharach, Annette Langer-Gould, Nicolas Collongues, and Petra Ijäs.

    SPECIAL REPORT: A Discussion with Mary Post (Part 2)

    Play Episode Listen Later Jun 28, 2021 12:02

    This second installment in our two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.

    SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective

    Play Episode Listen Later Jun 24, 2021 31:19

    Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.

    SPECIAL REPORT: A Discussion With Mary Post (Part 1)

    Play Episode Listen Later Jun 21, 2021 11:13

    This first installment of a two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.

    SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists

    Play Episode Listen Later Jun 19, 2021 11:32

    Dr. Jeff Burns, Director of the University of Kansas Alzheimer's Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.

    SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact

    Play Episode Listen Later Jun 17, 2021 30:37

    Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.

    A Discussion With Dr. John Quinlan; Readmission Risk for RCVS

    Play Episode Listen Later Jun 14, 2021 31:13

    The first segment features Dr. Stacey Clardy in conversation with 2021 Ted Burns Humanism in Neurology Award recipient Dr. John Quinlan. In the second part of the podcast, Dr. Andy Southerland discusses the risk of readmission following inpatient admission for reversible cerebral vasoconstriction syndrome with Dr. Santiago Ortega-Gutierrez.

    discussion risk journal neurology quinlan readmission rcvs stacey clardy andy southerland
    Physical Therapy Referrals For Back Pain; The SELECT Trial for Large Vessel Occlusion

    Play Episode Listen Later Jun 7, 2021 26:02

    In the first segment, Dr. Jeff Ratliff discusses primary care management for acute sciatica and physical therapy referrals with Dr. Julie Fritz. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Amrou Sarraj about efficacy and safety of direct endovascular thrombectomy compared to bridging therapy in patients with large vessel occlusions.

    Alzheimer's Disease Diagnostics & Treatments (Neurology Recall June 2021)

    Play Episode Listen Later Jun 1, 2021 58:40

    This month's replay of past episodes showcases a selection of interviews by Drs. Jeff Burns, Jason Crowell, and Gregg Day on updates in Alzheimer's disease diagnostics and the impact of future therapies, featuring Drs. Michael Weiner, Randall Bateman, Erik Musiek, Joseph Therriault, and Yvette Sheline.

    Concussion Biomarkers in Saliva; Non-invasive Biomarkers of Intracranial Pressure

    Play Episode Listen Later May 31, 2021 20:35

    In the first segment, Dr. Alex Menze speaks with Prof. Antonio Belli about the role of salivary small non-coding RNAs in the diagnosis of sport-related concussion. In the second part of the podcast, Dr. David Lapides talks to Dr. Linda D’Antona about the utility of brain MRI and ophthalmic biomarkers for the prediction of intracranial hypertension.

    Pregnancy and Stroke; Myasthenia Gravis and Pregnancy

    Play Episode Listen Later May 24, 2021 27:29

    In the first segment, Dr. Stacey Clardy speaks with Dr. Petra Ijäs about the incidence of stroke during pregnancy or puerperium in Finland from 1987-2016. In the second part of the podcast, Dr. David Lapides talks with Dr. Emma Ciafaloni about management of pregnancy in myasthenia gravis.

    Natural History of PLS; Stratifying Risk in ICH

    Play Episode Listen Later May 17, 2021 22:43

    In the first segment, Dr. Jason Crowell discusses a natural history study of “pure” primary lateral sclerosis with Dr. Anhar Hassan. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Roland Faigle about the assessment of critical care needs for patients with spontaneous intracerebral hemorrhage.

    Developing a Brain Machine Interface; Association of Huntington CAG Repeats With Cognition

    Play Episode Listen Later May 10, 2021 29:14

    In the first segment, Dr. Andy Southerland talks with Dr. Mijail Serruya about developing a brain-machine interface for patients with stroke. In the second part of the podcast, Dr. Jason Crowell discusses the relationship between CAG repeat length and cognition in adult patients with Dr. Jordan Schultz. 

    Claim Neurology® Podcast

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel